Frontlight ResearchEarly access
HIV trials in United Kingdom
5 of 11 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
- Where
- Birmingham, Liverpool, London
- Age
- 12 years and over
- People
- 564 worldwide
- Run by
- ViiV Healthcare
See details and how to joinNCT07650916 · EU 2024-518511-19-00 - Phase 2Taking peopleCombination Vaccination and Broadly Neutralising Antibody Therapy in HIV
- Where
- London, Oxford
- Age
- 18 years to 64 years
- People
- 48
- Run by
- University of Oxford
See details and how to joinNCT07054931 - No phaseTaking people#AWARE.HIV Europe: Supporting Healthcare Professionals to Find Undiagnosed HIV in European Hospitals: An Effectiveness-implementation Trial.
- Where
- Aylesbury, London
- Age
- 18 years and over
- People
- 5,200 worldwide
- Run by
- Casper Rokx
See details and how to joinNCT06900829 - Phase 2Taking peopleA Randomised Placebo Controlled Trial of ART Plus Dual Long-acting HIV-specific Broadly Neutralising Antibodies (bNAbs).
- Where
- Brighton, Edinburgh, London, Manchester, Oxford
- Age
- 18 years to 60 years
- People
- 72 worldwide
- Run by
- Imperial College London
See details and how to joinNCT04319367 · EU 2024-514564-13-00 - Phase 3Taking peopleEfficacy of Doravirine + Dolutegravir Dual Therapy in the Context of Antiretroviral Therapy Switch
- Where
- London
- Age
- 18 years and over
- People
- 150 worldwide
- Run by
- Chelsea and Westminster NHS Foundation Trust
See details and how to joinNCT04892654 · EU 2023-509751-14-03